Lausa, Edralyn G.
HRN: 14-66-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
CEFTRIAXONE 1G (VIAL)
02/15/2023
02/22/2023
IV
2gms
OD
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes